{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:30Z","timestamp":1792783530556,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Golden Jubilee Research Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ahj.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T08:03:15Z","timestamp":1522742595000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial"],"prefix":"10.1016","volume":"201","author":[{"given":"Thomas J.","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith G.","family":"Oldroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"McEntegart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rocchiccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katriona","family":"Brooksbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"McConnachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"110115","key":"10.1016\/j.ahj.2018.03.010_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2018.03.010_bb0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.03.010_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehl562","article-title":"Recurrent angina after coronary revascularization: a clinical challenge","volume":"28","author":"Abbate","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Camici","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.03.010_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.117.028991","article-title":"Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease","volume":"136","author":"Berry","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0035","first-page":"284","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2018.03.010_bb0040","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0045","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0050","first-page":"522","article-title":"Coronary microcirculation in health and disease. Summary of an NHLBI workshop","volume":"95","author":"Chilian","year":"1997"},{"key":"10.1016\/j.ahj.2018.03.010_bb0055","doi-asserted-by":"crossref","first-page":"j1194","DOI":"10.1136\/bmj.j1194","article-title":"Prognosis of undiagnosed chest pain: linked electronic health record cohort study","volume":"357","author":"Jordan","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2018.03.010_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9149(74)90743-7","article-title":"Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve","volume":"33","author":"Gould","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2018.03.010_bb0070","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel index for invasively assessing the coronary microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehx226","article-title":"Coronary artery disease: physiology and prognosis","volume":"38","author":"Ford","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5793","article-title":"Prognosis research strategy (PROGRESS) 4: stratified medicine research","volume":"346","author":"Hingorani","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2018.03.010_bb0085","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","article-title":"Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease","volume":"131","author":"Lee","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0095","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.03.010_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2018.03.010_bb0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0735-1097(94)90750-1","article-title":"Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina","volume":"23","author":"Kaski","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000227","article-title":"Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years","volume":"2","author":"Sato","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.03.010_bb0115","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1253\/circj.CJ-10-0292","article-title":"Prognostic effects of calcium channel blockers in patients with vasospastic angina","volume":"74","author":"Nishigaki","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.CIR.65.2.281","article-title":"Exacerbation of vasotonic angina pectoris by propranolol","volume":"65","author":"Robertson","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0125","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/heartjnl-2016-310129","article-title":"Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial","volume":"103","author":"Williams","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2018.03.010_bb0130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2018.03.010_bb0140","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/eurheartj\/ehl040","article-title":"Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study","volume":"27","author":"Johnson","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0145","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0150","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2018.03.010_bb0155","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ije\/18.3.607","article-title":"Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology","volume":"18","author":"Cook","year":"1989","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.89.3.1013","article-title":"Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography","volume":"89","author":"De Bruyne","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0170","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/01.CIR.0000017199.09457.3D","article-title":"Coronary thermodilution to assess flow reserve: validation in humans","volume":"105","author":"Pijls","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0175","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0180","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.CIR.92.9.2426","article-title":"Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans","volume":"92","author":"Lerman","year":"1995","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.ahj.2018.03.010_bb0185","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0190","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCULATIONAHA.110.967406","article-title":"Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis","volume":"122","author":"Reriani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0195","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle angina questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0205","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.109.887380","article-title":"Angina symptoms are associated with mortality in older women with ischemic heart disease","volume":"120","author":"Berecki-Gisolf","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.03.010_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00132580-200207000-00002","article-title":"The Seattle angina questionnaire: reliability and validity in women with chronic stable angina","volume":"4","author":"Kimble","year":"2002","journal-title":"Heart Dis"},{"key":"10.1016\/j.ahj.2018.03.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(17)33470-8","article-title":"Reliability and responsiveness of Seattle angina questionnaire in women with coronary artery disease","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.03.010_bb0225","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00392-013-0568-z","article-title":"Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris","volume":"102","author":"Jespersen","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0240","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.03.010_bb0245","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/eurheartj\/ehs246","article-title":"Coronary microvascular dysfunction in the clinical setting: from mystery to reality","volume":"33","author":"Herrmann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.03.010_bb0250","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0002-9149(88)91180-0","article-title":"\"Microvascular angina\" as a cause of chest pain with angiographically normal coronary arteries","volume":"61","author":"Cannon","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0255","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jacc.2015.12.053","article-title":"Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis","volume":"67","author":"Lee","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.03.010_bb0260","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/eurheartj\/ehu312","article-title":"The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology","volume":"35","author":"Kirchhof","year":"2014","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318300851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318300851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:15Z","timestamp":1757570475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318300851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":52,"alternative-id":["S0002870318300851"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.03.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}